FDA Label for Nasal Relief Rite Aid

View Indications, Usage & Precautions

Nasal Relief Rite Aid Product Label

The following document was submitted to the FDA by the labeler of this product Rite Aid. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredient                                       Purpose



Oxymetazoline Hydrochloride 0.05%        Nasal decongestant


Warnings



Warnings
Do not use this product if you have heart disease • high
blood pressure • thyroid disease
• diabetes • or difficulty in urination due to enlargement of
the prostate gland


When Using This Product



 • Do not exceed recommended
dosage. • This product may cause temporary
discomfort such as burning, stinging, sneezing, or an
increase in nasal discharge. • The use of this
container by more than one person may spread
infection. • Do not use for more than 3 days. Use only as
directed. • Frequent or prolonged use may cause nasal
congestion to recur or worsen.


Directions



Before using the first time, remove the protective cap from the tip and prime pump by depressing pump firmly several times.
To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress rim with a firm, even stroke and sniff deeply. Wipe nozzle clean after use. • adults and children 6 to under12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 1 0 to 1 2 hours. Do not exceed 2 doses within any 24-hour period • children under 6 years of age: consult a doctor


Inactive Ingredients




Benzalkonium Chloride
Chlorhexidine Gluconate
Citric Acid
Disodium EDTA
Fragrance
Purified Water
Sodium Citrate
Sodium Hydroxide
Tyloxapol


* Please review the disclaimer below.